Our commitments
We do everything right for your skin
nunii Laboratoire is a French biomedical research laboratory whose vision is to bring to the international aesthetic medicine market a portfolio of brands that anticipate and satisfy the desires and needs of women and men to have healthy beautiful skin.
From our very foundations nunii Laboratoire’s ethos has been based on a continuous improvement approach which aims to take into consideration the social economic and environmental impact both positive and negative of all its business areas. The objective being, to define concrete actions to meet economic based challenges in order to reconcile, profitability with the environment and social equity.
Safety & Efficacy
We at nunii Laboratoire commit that our ingredients and products are clinically proven and safe for people with limited impact on the environment. Our objective is to meet both doctor and patient expectations. nunii laboratoire acts by limiting controversial and irritating ingredients in our products and by communicating this openly and transparently. We strive for the highest ethics in our selection of and practices with partners and clients.
Nunii by Novelskin
For more than 13 years, Novelskin’s mission has been to select and market exclusively on the French medical aesthetics market innovative product ranges that meet the requirements of health and beauty professionals. In recent years, Novelskin has been aimed at a general public clientele through expert ranges recommended in addition to medical-aesthetic procedures, or responding to specific concerns (pigment spots, acne, wrinkles and fine lines, sagging oval, dull complexion …).
Guided by a shared sense of innovation in medical aesthetics, Novelskin and Nunii were already working closely together in the French market. Nunii, a French biomedical research laboratory, works with the Mediterranean Center for Molecular Medicine under the responsibility of INSERM (National Institute of Health and Medical Research) and UNS (University of Nice Sophia Antipolis). This is at the heart of an ambitious fundamental research program on the mechanisms of melanogenesis, which are at the heart of the development of Nunii products.
With the acquisition of Nunii, Novelskin now becomes a key player in the treatment of pigmentation and acne with its own R&D laboratory. Novelskin aims to develop the brand on the French market and internationally. New products will be marketed from 2022.
“As a finder of high-performance and efficient brands, we have found in Nunii a quality of products and R&D that meets our requirements.”
Karine POPIS-CLAUDE, Novelskin CEO
